1. Griep EN, Boersma JW, Lentjes EG, et al. Function of the
hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain. J
Rheumatol 1998;25:1374–81. 2. Anonymous. Is fibromyalgia caused by a glycolysis impairment? Nutr
Rev 1994;52(7):248–50. 3. Wolfe F, Ross K, Anderson J, Russell J. Aspects of fibromyalgia in the
general population: Sex, pain threshold, and FM symptoms. J Rheumatol
1995;22(1):151–5. 4. Yunus MB, Masi AT, Aldag JC. Short term effects of ibuprofen in
primary fibromyalgia syndrome: a double blind, placebo controlled trial. J Rheumatol
1989;16(4):527–32. 5. Kaartinen K, Lammi K, Hypen M, et al. Vegan diet alleviates
fibromyalgia symptoms. Scand J Rheumatol 2000;29:308–13. 6. Smith JD, Terpening CM, Schmidt SOF, Gums JG. Relief of fibromyalgia
symptoms following discontinuation of dietary excitotoxins. Ann Pharmacother
2001;35:702–6. 7. Wilke W. Fibromyalgia: Recognizing and addressing the multiple
interrelated factors. Postgrad Med 1996;100(1):153–70. 8. Carette S. Fibromyalgia 20 years later: What have we really
accomplished? J Rheumatol 1995;22(4):590–4. 9. Mengshail AM, Komnaes HB, Forre O. The effects of 20 weeks of physical
fitness training in female patients with fibromyalgia. Clin Exp Rheumatol
1992;10:345–9. 10. Gowans SE, deHueck A, Voss S, Richardson M. A randomized, controlled
trial of exercise and education for individuals with fibromyalgia. Arthritis Care Res
1999;12:120–8. 11. Mannerkorpi K, Nyberg B, Ahlmen M, Ekdahl C. Pool exercise combined
with an education program for patients with fibromyalgia syndrome. A prospective, randomized
study. J Rheumatol 2000;27:2473–81. 12. Fava M, Rosenbaum JF, MacLaughlin R, et al. Neuroendocrine effects of
S-adenosyl-L-methionine, a novel putative antidepressant. J Psychiatr Res
1990;24:177–84. 13. Bell KM, Potkin SG, Carreon D, Plon L. S-adenosylmethionine blood
levels in major depression: changes with drug treatment. Acta Neurol Scand
1994;154(suppl):15–8. 14. Bell KM, Potkin SG, Carreon D, Plon L. S-adenosylmethionine blood
levels in major depression: changes with drug treatment. Acta Neurol Scand
1994;154(suppl):15–8. 15. Puttini PS, Caruso I. Primary fibromyalgia syndrome and
5-hydroxy-L-tryptophan: a 90-day open study. J Int Med Res 1992;20:182–9. 16. Moldofsky H, Warsh JJ. Plasma tryptophan and musculoskeletal pain in
non-articular rheumatism (“fibrositis syndrome”). Pain
1978;5:65–71. 17. Caruso I, Sarzi Puttini P, Cazzola M, Azzolini V. Double-blind study
of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome. J
Int Med Res 1990;18:201–9. 18. Eisinger J, Zakarian H, Plantamura A, et al. Studies of transketolase
in chronic pain. J Adv Med 1992;5:105–13. 19. Eisinger J, Bagneres D, Arroyo P, et al. Effects of magnesium, high
energy phosphates, piracetam, and thiamin on erythrocyte transketolase. Magnesium Res
1994;7(1):59–61. 20. Steinberg CL. The tocopherols (vitamin E) in the treatment of primary
fibrositis. J Bone Joint Surg 1942;24:411–23. 21. Tavoni A, Jeracitano G, Cirigliano G. Evaluation of
S-adenosylmethionine in secondary fibromyalgia: A double-blind study. Clin Exp
Rheumatol 1998;16:106–7 [letter]. 22. Tavoni A, Vitali C, Bombardieri S, et al. Evaluation of
S-adenosylmethionine in primary fibromyalgia: A double-blind crossover study. Am J
Med 1987;83(suppl 5A):107–10. 23. Volkmann H, Norregaard J, Jacobsen S, et al. Double-blind,
placebo-controlled cross-over study of intravenous S-adenosyl-L-methionine in patients with
fibromyalgia. Scand J Rheumatol 1997;26:206–11. 24. Jacobsen S, Danneskiold-Samsoe B, Andersen RB. Oral
S-adenosylmethionine in primary fibromyalgia: Double-blind clinical evaluation. Scand J
Rheumatol 1991;20:294–302. 25. Abraham G, Flechas J. Management of fibromyalgia: Rationale for the
use of magnesium and malic acid. J Nutr Med 1992;3:49–59. 26. Russell J, Michalek J, Flechas J, et al. Treatment of fibromyalgia
syndrome with SuperMalic: A randomized, double-blind, placebo-controlled, crossover pilot
study. J Rheumatol 1995;22(5):953–7. 27. Citera G, Arias MA, Maldonado-Cocco JA, et al. The effect of
melatonin in patients with fibromyalgia: a pilot study. Clin Rheumatol
2000;19:9–13. 28. Kaplan KH, Goldberg DL, Galvin-Naduea M. The impact of a
meditation-based stress reduction program on fibromyalgia. Gen Hosp Psychiatry
1993;15:284–9. 29. Sprott H, Franke S, Kluge H, Hein G. Pain treatment of fibromyalgia
by acupuncture. Rheumatol Int 1998;18:35–6. 30. Waylonis GW. Long-term follow-up on patients with fibrositis treated
with acupuncture. Ohio State Med J 1977;73:299–302. 31. Deluze C, Bosia L, Zirbs A, et al. Electroacupuncture in
fibromyalgia: results of a controlled trial. BMJ 1992;305(6864):1249–52. 32. Berman BM, Ezzo J, Hadhazy V, Swyers JP. Is acupuncture effective in
the treatment of fibromyalgia? J Fam Pract 1999;48:213–8. 33. Wolfe F. The clinical syndrome of fibrositis. Am J Med
1986;81(Supp 3A):7–14. 34. Blunt KL, Moez HR, Rajwani MH, Guerriero RC. The effectiveness of
chiropractic management of fibromyalgia patients: a pilot study. J Manipulative Physiol
Ther 1997;20:389–99. 35. Hains G, Hains F. Combined ischemic compression and spinal
manipulation in the treatment of fibromyalgia; a preliminary estimate of dose and efficacy.
J Manipulative Physiol Ther 2000;23:225–30. |